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TECHNICAL NOTE
Preliminary Experience with 3-Tesla MRI
and Cushing’s Disease
LouisJ. Kim,M.D.,1Gregory P. Lekovic,M.D., Ph.D., J.D.,1WilliamL.White,M.D.,1
andJohnKaris,M.D.2
ABSTRACT
Because radiographic visualization of a pituitary microadenoma is fre-
quently difficult, we hypothesized that microadenomas associated with Cushing’s
disease may be better resolved and localized via acquisition with 3-Tesla (3T)
compared with standard 1.5-Tesla (1.5T) magnetic resonance imaging (MRI).
Five patients (four females, one male; age range, 14 to 50 years old) with endocrine
and clinical confirmation of Cushing’s disease underwent 1.5T and 3T MRI and
corticotropin-releasing hormone stimulation/inferior petrosal sinus sampling
(IPSS) as part of their preoperative evaluation. All patients underwent a transnasal
trans-sphenoidal pituitary adenomectomy. In two cases, tumor could not be
localized on either 1.5T or 3T MRI on the initial radiologist’s review. In two
other cases, the 1.5T images delineated the tumor location, but it was more clearly
defined on 3T MRI. In a fifth case, the 1.5T MRI showed a probable right-sided
adenoma. However, on both 3T MRI and at surgical exploration the tumor was
localized on the left side. Therefore, in three of five cases, 3T MRI either more
clearly defined tumors seen on 1.5T MRI or predicted the location of tumor
contrary to the 1.5T images. IPSS identified the correct side of the tumor in two
patients, an incorrect location in two patients, and was indeterminate in one
patient. In certain cases 3T MRI is a new tool that may ameliorate imaging
difficulties associated with adrenocorticotrophic hormone-secreting pituitary ad-
enomas. Its role in the diagnostic evaluation of Cushing’s disease will be better
defined with further experience.
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Surgical exploration for Cushing’s disease in
the absence of confirmation by imaging or later-
alization by inferior petrosal sinus sampling
(IPSS) can lower cure rates.1–3 Although standard
magnetic resonance imaging (MRI) scanners use
1.5T magnets, MRI with stronger magnetic field
strength may offer improved image quality and
spatial resolution in conditions with subtle differ-
ences between normal and abnormal tissue.4,5 We
hypothesized that microadenomas associated with
Cushing’s disease might be visualized with better
resolution and accuracy using high-strength MRI.
We present five cases of adrenocorticotrophic
hormone (ACTH)-secreting adenomas that
showed ambiguous radiographic evidence of
tumor on standard MRI. Subsequently, 3T MRI
was used to assess the utility of this modality in
identifying adenomas associated with Cushing’s
disease.
MATERIALS AND METHODS
Patients
Five patients (four females, one male; age range, 14
to 50 years old) with endocrine and clinical con-
firmation of Cushing’s disease underwent 1.5T and
3T MRI as part of their preoperative evaluation.
Their hospital and office clinic records were re-
viewed retrospectively. At presentation, their symp-
toms included hypertension, truncal obesity,
headaches, buffalo hump, moon facies, abdominal
striae, and hypertension. All patients underwent
corticotropin-releasing hormone stimulation and
IPSS, which was lateralized in four patients. In the
fifth patient, asymmetric venous anatomy precluded
left-sided sampling. All patients underwent a trans-
nasal, trans-sphenoidal pituitary adenomectomy.
Magnetic Resonance Imaging Technique
Conventional 1.5 T MRI was performed at outside
imaging facilities, and films were reviewed. 3T scans
were obtained from a GE (General Electric,
Milwaukee, WI) 3T MRI scanner running VH3
level software. Pre- and postcontrast MRIs were
obtained using an inversion prepared three-dimen-
sional (3D) spoiled gradient-recalled (MPRAGE)
sequences in the coronal plane. The scan parameters
were as follows: repetition time¼ 5.2 milliseconds;
inversion preparation time¼ 300 milliseconds; echo
time¼ 2.1 milliseconds; flip angle¼ 13 degrees; slice
thickness¼ 1.8 mm; field of view (FOV)¼ 24 cm;
scan matrix¼ 256 256 63 at FOV in phase;
reconstruction matrix¼ 512 512 124; number
of excitations (NEX)¼ 2; and relative bandwidth
(rBW)¼ 63.4 kHz. Imaging findings were based on
the radiologists’ official report at the time of the
study (Table 1).
Table 1 Patient Characteristics, Tumor Imaging Results, and Inferior Petrosal Sinus Sampling Lateralization
Patient Age/Sex 1.5T MRI 3T MRI IPSS
Surgical
Location
of Tumor Retrospective Reanalysis
1 37/F Stalk deviation Hypodensity
Rt anterior
Lt side Rt anterior Better delineated on 3T
2 14/F Enlarged,
symmetric gland
Enlarged,
symmetric gland
Rt side Anterior midline Indeterminate on 1.5T
or 3T
3 35/F Slight Lt hypodensity Clear Lt
hypodensity
Lt side Lt side Better delineated on 3T
4 50/F Indeterminate Indeterminate Lt side Lt side Indeterminate on 1.5T
or 3T
5 34/M Rt-sided tumor Lt-sided tumor Equivocal Lt side Better delineated on 3T
T, Tesla; IPSS, inferior petrosal sinus sampling; F, female; M, male; Lt, left; Rt, right.
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RESULTS
Imaging Outcomes
Based on the 1.5T MRI studies, two patients (cases
1 and 3, Table 1) had correctly lateralized lesions,
two patients (cases 2 and 4) had indeterminate
lesions, and one patient (case 5) had an incorrectly
lateralized lesion. Based on the 3T MRI, two
patients (cases 1 and 3, Fig. 1) had adenomas
more clearly delineated than on 1.5T MRI, two
patients (cases 2 and 4, same as 1.5T MRI) had
adenomas in indeterminate locations (Fig. 2), and
one patient (case 5) had an adenoma correctly
lateralized on the left (Fig. 3). In the latter, 1.5T
MRI had incorrectly identified the adenoma as
‘‘probable’’ on the right side. IPSS identified the
correct side of the tumor in two patients (cases 3 and
4), an incorrect location in two patients (cases 1 and
2), and an indeterminate location in one patient
(case 5) due to venous asymmetry.
A retrospective, side-by-side comparison of
1.5T and 3T MRI was performed by a neuroradi-
ologist (JK). In two cases, evidence of tumor and its
location was perceptible and accurate on 1.5T MRI.
However, in these same cases, 3T MRI better
delineated the lesions. In cases 2 and 4, both 1.5T
and 3T MRI failed to identify the presence and
location of the tumor. In one of these cases, the
intrasellar contents were clearly enlarged and ab-
normal, but no definite tumor mass could be per-
ceived. In one case (case 5), the tumor was difficult
to ascertain on 1.5T MRI but was well delineated as
left-sided on 3T MRI. This left-sided abnormality
was confirmed at surgery (Table 1).
Clinical Outcomes
In all cases, the location of the adenoma and neo-
plastic tissue with ACTH-immunoreactivity was
confirmed histologically. During a brief follow-up
(range, 5 to 12 months), no patient has shown
evidence of recurrent or residual disease.
DISCUSSION
Unfortunately, absent radiographic evidence of
tumor is often associated with Cushing’s disease.6
In such cases, IPSS remains a useful tool in
Figure 1 (Case 3) (A) T1-weighted coronal 1.5T MRI with contrast shows slight hypointensity on the left side of the sella
(arrow) consistent with a left-sided pituitary mass. (B) T1-weighted 3T coronal MRI with contrast shows marked
differentiation of the hypointense tumor (arrow) and surrounding normal gland.
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the diagnostic algorithm; however, its potential
for inaccuracy is well documented.7–9 Given
these shortcomings, that the improved resolution
and image quality afforded by 3T MRI
might better differentiate ACTH-secreting mi-
croadenomas from normal gland is an attractive
hypothesis.
Wolfsberger et al10 used T1-weighted 3D
magnetization-prepared rapid-acquisition gra-
dient-echo sequences on 3T MRI to study 42
Figure 2 (Case 4) (A) T1-weighted coronal 1.5T MRI and (B) 3T MRI with contrast show enhancement of the intrasellar
contents with no clear radiographic definition of the tumor. IPSS indicated a strong left-sided ACTH gradient with a high
central-to-peripheral ratio. A left-sided ACTH-secreting adenoma was confirmed at surgery. IPSS, inferior petrosal sinus
sampling; ACTH, adrenocorticotropic hormone.
Figure 3 (Case 5) (A) T1-weighted coronal 1.5T MRI with contrast shows no clear tumor margins. The radiologist’s
interpretation stated ‘‘probable 5.5-mm right-sided pituitary adenoma.’’ IPSS could only be obtained on the right side. (B)
T1-weighted coronal 3T MRI shows a left-sided hypointensity relative to the surrounding enhancing gland (arrow). This
finding is consistent with a pituitary microadenoma, which was confirmed during surgical exploration. IPSS, inferior
petrosal sinus sampling.
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cavernous sinuses. This modality was used to
minimize susceptibility artifacts in the sellar
and parasellar region. They concluded that 3T
MRI provided superior delineation of an intra-
sellar tumor involved with the cavernous sinus
compared with standard MRI techniques. How-
ever, they did not compare standard MRI to 3T
MRI with respect to specific tumor types. In fact,
the literature lacks any discussion of the potential
advantages of 3T MRI compared with 1.5T
MRI in identifying ACTH-secreting pituitary
adenomas.
Our small and highly selected population
precludes strong conclusions. Nonetheless, 3T
MRI either further delineated or newly demon-
strated a pituitary microadenoma in three of the five
cases, even though the findings were equivocal in
the remaining two cases. In comparison, 1.5T MRI
predicted two cases correctly, two equivocally, and
one incorrectly. IPSS predicted two cases correctly
and two incorrectly; one was technically infeasible.
IPSS correctly lateralized the tumor in case 4 but
was inaccurate in case 2. Interestingly, 1.5T MRI
(case 5) and IPSS (case 1) incorrectly lateralized the
tumor in one case each. Although 3T did not
incorrectly lateralize a tumor, it failed to determine
the site of tumor in two cases. Both 1.5T and 3T
MRI were equivocal in the same two cases (cases 2
and 4).
That 1.5T and 3T MRI were indetermi-
nate in the same two cases indicates that certain
ACTH-secreting microadenomas will likely con-
tinue to be indistinguishable from adjacent nor-
mal gland, irrespective of the magnet strength
used in MRI. When, however, a subtle imaging
abnormality exists (e.g., cases 1 and 3), the
increased magnetic strength of the 3T scanner
may be superior to 1.5T in amplifying these
radiographic differences. On the basis of case 5,
some adenomas appear to be radiographically
indeterminate on 1.5T MRI yet determinate on
3T MRI. Undoubtedly, the subtle differences
between 1.5T and 3T MRI will be exploited as
refinements in head coils and imaging sequences
are introduced.
CONCLUSIONS
In certain cases, the new tool of 3T MRI may
ameliorate the imaging difficulties associated with
ACTH-secreting pituitary adenomas. Although the
role of 3T MRI needs to be further defined, the
modality may be a useful adjunct in the evaluation
algorithm for Cushing’s disease and in planning the
management of certain cases.
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